Eliglustat

Eliglustat, sold under the brand name Cerdelga, is a medication used for the treatment of Gaucher's disease. It was discovered at the University of Michigan, developed by Genzyme Corp, and was approved by the FDA in August 2014.[3] Commonly used as the tartrate salt, the compound is believed to work by inhibition of glucosylceramide synthase.[4][5] According to an article in Journal of the American Medical Association the oral substrate reductio... [wikipedia]